One of the most crucial elements of any high-tech start-up's survival -- much less evolution -- is the money backing the enterprise. Is it 'smart money?' Is it 'patient money?' Is it 'connected money?'
With corporate coffers brimming with cash, merger and acquisition activity is percolating again. So, too, is the pace of stock trading investigations by the Securities and Exchange Commission into such transactions.